Valuation Novartis AG Mexican S.E.

Stocks

End-of-day quote Mexican S.E. Other stock markets 07/08/2026			5-day change	1st Jan Change
2,677.00 ^MXN	-1.22%		-1.22%	+7.08%

08-07	Swiss Market Index Ends Week Upbeat; Amrize Falls	MT
08-07	UK Regulator OKs Novartis' Treatment for Chronic Spontaneous Urticaria	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	196,458	194,448	207,167	195,514	266,003	296,432	-	-
Change	-	-1.02%	6.54%	-5.62%	36.05%	11.44%	-	-
Enterprise Value (EV) ¹	204,649	203,482	219,178	213,458	289,870	329,546	324,250	317,312
Change	-	-0.57%	7.71%	-2.61%	35.8%	13.69%	-1.61%	-2.14%
P/E	8.2x	28.3x	14.1x	16.5x	19.2x	22.1x	18.9x	16.4x
PBR	2.9x	3.23x	4.41x	4.52x	5.73x	6.24x	5.82x	5.22x
PEG	-	-0.4x	0x	-1x	0.9x	-9.64x	1.1x	1.1x
Capitalization / Revenue	3.81x	3.85x	4.44x	3.78x	4.69x	5.15x	4.85x	4.56x
EV / Revenue	3.96x	4.03x	4.7x	4.13x	5.11x	5.72x	5.3x	4.88x
EV / EBITDA	11.2x	10.9x	12.2x	10.2x	12.4x	14.3x	12.9x	11.7x
EV / EBIT	12.3x	12.2x	13.4x	10.9x	13.2x	15.1x	13.7x	12.4x
EV / FCF	15.4x	17x	16.6x	13.1x	16.5x	22.7x	20.1x	16.8x
FCF Yield	6.49%	5.87%	6.01%	7.61%	6.07%	4.4%	4.98%	5.95%
Dividend per Share ²	3.36	3.5	3.823	3.856	-	4.367	4.555	4.738
Rate of return	3.83%	3.87%	3.79%	3.94%	-	2.8%	2.92%	3.04%
EPS ²	10.71	3.19	7.15	5.92	7.21	7.045	8.252	9.485
Distribution rate	31.4%	110%	53.5%	65.1%	-	62%	55.2%	50%
Net sales ¹	51,626	50,545	46,660	51,722	56,674	57,584	61,123	64,991
EBITDA ¹	18,246	18,613	17,937	21,006	23,415	23,083	25,093	27,161
EBIT ¹	16,588	16,665	16,372	19,494	21,889	21,778	23,631	25,619
Net income ¹	24,021	6,955	14,854	11,939	13,967	13,780	15,358	17,285
Net Debt ¹	8,191	9,034	12,011	17,944	23,867	33,114	27,817	20,880
Reference price ²	87.82	90.40	100.79	97.79	138.63	155.96	155.96	155.96
Nbr of stocks (in thousands)	2,237,092	2,150,980	2,055,460	1,999,270	1,918,792	1,900,715	-	-
Announcement Date	02/02/22	01/02/23	31/01/24	31/01/25	04/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.6x	12.29x	24.81x	0.58%	1,057B
JOHNSON & JOHNSON	28.84x	-	-	2.07%	625B
ABBVIE INC.	32.34x	7.35x	15.3x	2.81%	435B
ROCHE HOLDING AG	20.47x	4.85x	12.02x	2.72%	363B
NOVARTIS AG	22.14x	5.72x	14.28x	2.8%	296B
ASTRAZENECA PLC	20.58x	4.25x	12.07x	2.07%	249B
AMGEN INC.	25.76x	6.79x	12.06x	2.45%	222B
NOVO NORDISK A/S	13.84x	4.97x	10.44x	3.68%	209B
GILEAD SCIENCES, INC.	-41.38x	5.93x	33.46x	2.47%	165B
Average	17.35x	6.52x	16.80x	2.41%	402.31B
Weighted average by Cap.	24.44x	8.09x	18.31x	1.98%